Colorectal Tumor
Conditions
Keywords
cachexia, nutrition, cancer, colorectal tumor
Brief summary
Cachexia associated with cancer is a grave and most of the time irreversible common situation. It seems independent from the size of the tumor or from its metastatic character. The consequences for the management of the patient are major and exceed widely the frame of the nutrition. Undernutrition of patients with cancer is described by a decrease of the energy contributions and a loss of muscular and fat mass, leading to a progressive functional deficiency which can go to the cachectic state. Actually, clinical criteria are proposed allowing to characterize the state of pre-cachexia but it remain too indistinct to allow an early and efficient screening and set up effective measures of prevention of the cachexia, to avoid the loss of muscular tissue and the cast iron of the energy reserves. It is necessary to have clinical and biological markers with diagnostic aim and forecasts during the situations precedents the appearance of cachexia. The present study will allow calibrating a longitudinal study, which could confirm the value of measures made for the diagnosis of pre-cachexia.
Interventions
PROCEDUREBiopsy of adipose and muscular tissue
OTHERBlood sampling
OTHERCalorimetry
OTHERImpedance measure
Evaluation of physical composition (non-invasive method)
OTHEREvaluation of nutritional status
Nutritional status will be assessed by using the Mini Nutritional Assessment (MNA) questionnaire and a scale that evaluates anorexia
OTHEREvaluation of physical performance
This will be assessed by using a tiredness scale named Echelle Visuelle Analogique (EVA) in french
OTHEREvaluation of muscular strength
Muscular strength will be assessed thanks to the Handgrip Strength Test and the Short Physical Performance Battery (SPPB)
OTHEREvaluation of emotional status
The emotional status wil be assessed thanks to the Yesavage Geriatric Depression Scale (GDS)
OTHEREvaluation of functional status
The functional status will be assessed by using the Activity of Daily Life (ADL) questionnaire and the Instrumental Activities of Daily Living (IADL) Questionnaire
Sponsors
Hospices Civils de Lyon
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 70 years * Colorectal tumor resection with/without synchronous metastases
Exclusion criteria
* Emergency resection of colorectal tumor * Unresectable colorectal tumor with/without synchronous metastases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| biological and radiological markers | During perioperative period (from date of consent until discharge from the hospital, up to 30 postoperative days) | Validated criteria of cachexia, pre-cachexia and sarcopenia are applied. Systematic preoperative measures (TNFα, leptin, ghrelin) and CT scanning of the abdomen/pelvis are performed for all patient enrolled. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| activity of the ATGL | During perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days) | The activity of ATGL is determined by liquid scintillation counting. |
| Body composition | During perioperative period (from date of consent until discharge from the hospital, up to 30 postoperative days) | Body composition is evaluated utilizing computerized tomography(CT) images (at the third lumbar vertebral level). A muscle index is also calculated by normalizing muscle areas for height. |
| metabolic phenotype | During perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days) | metabolic phenotype is determinated by indirect calorimetry. |
| loss of fat body mass and/or lean body mass | During perioperative period (From date of consent until discharge from the hospital, up to 30 postoperative days) | Lean body mass and components (intracellular water and extracellular water as well as body cell mass) were calculated by tetrapolar bioelectrical impedance analysis |
Countries
France
Outcome results
None listed